Participant flow12

How many started, completed or left each group, period by period.

1 to 12 of 12

Period	Milestone	Group	Participants
Period 1: To End of OCS Reduction Phase	STARTED	Benra 30 mg	598
Period 1: To End of OCS Reduction Phase	COMPLETED	Benra 30 mg	563
Period 1: To End of OCS Reduction Phase	NOT COMPLETED	Benra 30 mg	35
Period 2: Maintenance Phase	STARTED	Benra 30 mg	563
Period 2: Maintenance Phase	COMPLETED	Benra 30 mg	536
Period 2: Maintenance Phase	NOT COMPLETED	Benra 30 mg	27
Period 3: Long Term Follow up Substudy	STARTED	Benra 30 mg	195
Period 3: Long Term Follow up Substudy	Asthma Treatment as Per Healthcare Provider Discretion	Benra 30 mg	195
Period 3: Long Term Follow up Substudy	>=50% Any Biologic	Benra 30 mg	78
Period 3: Long Term Follow up Substudy	>=50% Benra	Benra 30 mg	69
Period 3: Long Term Follow up Substudy	COMPLETED	Benra 30 mg	195
Period 3: Long Term Follow up Substudy	NOT COMPLETED	Benra 30 mg	0

Source ClinicalTrials.govtrials-2026-11-12-0.5.0

Sources 3

ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
ClinicalTrials.govNo license stated
NIH RePORTER's clinical studies and project filesPublic domain

Each source's terms

ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
ClinicalTrials.govnone stated
NIH RePORTER's clinical studies and project filesPublic domain (NIH RePORTER)

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

For software

Twenty rows a page, as JSON. No key.

GET https://conductscience.org/api/trials/v1/NCT03557307/flow